Shares in this Australian stem cell company are going nuts on an investment … – Business Insider Australia
Brisbane Times |
Shares in this Australian stem cell company are going nuts on an investment …
Business Insider Australia The US company will also get a six-month right of first refusal on Mesoblast's proprietary adult stem cell product candidates for the prevention and treatment of acute graft versus host disease, certain cancers, inflammatory bowel diseases and organ … Mesoblast Shares Climb as Celgene Invests $45 Million Mesoblast takes partnership with Celgene, shares rise 27pc Celgene And Mesoblast Enter Into Equity Placement and Right of First Refusal … |
